VERMODJE TURINOVER 10MG/TAB 100 TAB
TURINOVER
1 tablet contains:
Active substance: 10 mg of Chlorodehydromethyltestosterone;
 
Excipients:
Lactose Monohydrate, Magnesium Stearate.
 
Storage:
Store in cool dry place below 27°C
Keep out of reach of children.
 
Pharmocological action
TURINOVER (Chlorodehydromethyltestosterone) to treat oral steroids has a predominantly anabolic effect combined with a relatively weak androgenic effect. TURINOVER, like other steroidal androgens and anabolics, penetrates the cell membrane and forms a complex that penetrates the nucleus where it interacts with nuclear receptors. The complex formed is bound to DNA and, as a transcription factor, determines the synthesis of RNA and specific proteins.
TURINOVER has a predominantly anabolic effect, which is more pronounced at the level of skeletal muscles and bones, as well as tissues and organs with intense division.
 
Dosage & method of use
Standard male TURINOVER (Chlorodehydromethyltestosterone) doses will normally fall in the 15-30 mg range;
For performance enhancing athletes, TURINOVER doses normally range from 40-60 mg per day. Total use should fall in the 4-6 week range;
Standard female TURINOVER doses will normally fall in the 2.5-5mg per day range. Higher doses will lead to side effects. Total use should be kept in the 3-4 week range.
 
Side effects
Endocrine disorders: Chlorodehydromethyltestosterone in men can cause inhibition of spermatogenesis and impotence, prostatic hypertrophy, epididymitis, priapism. Boys may experience premature puberty, frequent erections;
Neurological disorders: agitation, confusion, insomnia, depression; For women (rarely): decreased secretion of gonadotropins; virilization phenomena (acne, hirsutism, coarseness of the voice, increased libido, menstrual disorders, clitoral hypertrophy, muscular development);
Other: during puberty, the epiphyseal zones of the bones with growth retardation may prematurely close.
 
Presentation
TURINOVER (Chlorodehydromethyltestosterone) 10 mg N50X2 Tablets.